Literature DB >> 16104897

Microsatellite instability and transitional cell carcinoma of the upper urinary tract.

Morgan Rouprêt1, Abdel-Rahmène Azzouzi, Olivier Cussenot.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16104897     DOI： 10.1111/j.1464-410X.2005.05671.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  Genomic Characterization of Upper Tract Urothelial Carcinoma.

Authors:  John P Sfakianos; Eugene K Cha; Gopa Iyer; Sasinya N Scott; Emily C Zabor; Ronak H Shah; Qinghu Ren; Aditya Bagrodia; Philip H Kim; A Ari Hakimi; Irina Ostrovnaya; Ricardo Ramirez; Aphrothiti J Hanrahan; Neil B Desai; Arony Sun; Patrizia Pinciroli; Jonathan E Rosenberg; Guido Dalbagni; Nikolaus Schultz; Dean F Bajorin; Victor E Reuter; Michael F Berger; Bernard H Bochner; Hikmat A Al-Ahmadie; David B Solit; Jonathan A Coleman
Journal:  Eur Urol       Date:  2015-08-14       Impact factor: 20.096

2.  Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms.

Authors:  Morgan Rouprêt; Pierre Colin
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

Review 3.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

4.  Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis.

Authors:  Laleh Ehsani; Adeboye O Osunkoya
Journal:  Tumour Biol       Date:  2014-05-30

Review 5.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

6.  Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.

Authors:  Jing Xie; Xue-Bin Zhang; Jin Wen; Yu-Shi Zhang; Han-Zhong Li
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

7.  Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.

Authors:  Myong Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

8.  Does reduced E-cadherin expression correlate with poor prognosis in patients with upper tract urothelial cell carcinoma?: A systematic review and meta-analysis.

Authors:  Bum Sik Tae; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

9.  Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations.

Authors:  Michael P Castro; Neal Goldstein
Journal:  J Immunother Cancer       Date:  2015-12-15       Impact factor: 13.751

10.  Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report.

Authors:  Joyce M Chen; G Kenneth Haines; William Lam; Asha Reddy; Meenakshi Mehrotra; Jane Houldsworth; Qiusheng Si
Journal:  Diagn Pathol       Date:  2021-06-14       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.